The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2021 | Mechanisms of acquired resistance against immunotherapy
Adam Schoenfeld, MD, Memorial Sloan Kettering Cancer Center, New York, NY, outlines his presentation at ELCC 2021 on mechanisms of acquired resistance against immunotherapy in patients with lung cancer. Dr Schoenfeld highlights the importance of understanding mechanisms of resistance in order to improve novel therapies and the current lack of research in this field. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.
Disclosures
None
